Physician profile
Mark H Olsen
NPI 1124330436
$1,929.25
in general payments reported to CMS, 2019-2025
23 companies · $296 in 2025
The $296 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $381 · 2020: $487 · 2021: $322 · 2022: $178 · 2023: $115 · 2024: $150 · 2025: $296.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $562.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $561.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $362.67 | 2020 | |
| Horizon Therapeutics Plc | $301.29 | 2019-2023 | Krystexxa |
| Integra Lifesciences Corporation | $227.18 | 2019-2022 | |
| Averitas Pharma INC. | $180.32 | 2023-2025 | Qutenza |
| Paratek Pharmaceuticals, INC. | $115.14 | 2021-2025 | Nuzyra |
| Abbott Laboratories | $110.76 | 2019-2024 | Proclaim |
| Djo, LLC | $100.07 | 2021-2025 | Cmf |
| Smith+Nephew, INC. | $79.94 | 2019-2023 | Grafix |
| Abbvie INC. | $66.87 | 2023-2024 | |
| Amgen INC. | $55.09 | 2024-2025 | Krystexxa |
| Tactile Systems Technology INC | $53.10 | 2019 | |
| Melinta Therapeutics, LLC | $40.54 | 2019-2020 | |
| Polarityte, INC. | $38.28 | 2019 | |
| Organogenesis INC. | $33.23 | 2020-2025 | Apligraf |
| Osteomed LLC | $30.73 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $28.06 | 2019 | |
| Depuy Synthes Sales INC. | $20.29 | 2019 | |
| Wright Medical Technology, INC. | $17.59 | 2019 | |
| Crossroads Extremity Systems, LLC | $16.89 | 2019 | |
| Bioventus LLC | $16.47 | 2019 | |
| Impactortho, INC. | $15.96 | 2024 | |
| Merck Sharp & Dohme LLC | $13.42 | 2019 | |
| Orthofix Medical, INC. | $5.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Olsen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.